Amlodipine-induced gingival overgrowth – Review and Case Report / Crescimento gengival induzido por Amlodipina - Revisão e Relato de Caso

Gingival overgrowth or enlargement is among one of the most important clinical features of gingival pathology frequently seen in periodontal clinic. Gingival overgrowth is a serious side e?ect that accompanies the use of amlodipine. Amlodipine is a comparatively new calcium channel blocker and is be...

Descripción completa

Detalles Bibliográficos
Autores: Goiris, Fabio Anibal, Pedroso, Thaynara Aparecida Alves, Coppla, Fabiana Madalozzo, de Geus, Juliana Larocca
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:Brasil
Institución:Instituto Superior de Educação Vera Cruz (VeraCruz)
Repositorio:Revista Veras
Idioma:portugués
OAI Identifier:oai:ojs2.ojs.brazilianjournals.com.br:article/33343
Acceso en línea:https://ojs.brazilianjournals.com.br/ojs/index.php/BRJD/article/view/33343
Access Level:acceso abierto
Palabra clave:Amlodipine
Gingival overgrowth
Periodontics.
Descripción
Sumario:Gingival overgrowth or enlargement is among one of the most important clinical features of gingival pathology frequently seen in periodontal clinic. Gingival overgrowth is a serious side e?ect that accompanies the use of amlodipine. Amlodipine is a comparatively new calcium channel blocker and is being used with increasing frequency in the management of hypertension and angina pectoris. Pertinent management depends on precisely diagnosing the origin of overgrowth. Cessation or change of drug and meticulous plaque control often leads to regression of the lesion, which however might need surgical correction for optimal maintenance of gingival health. The purpose of this article is to present a case report and highlight significant aspects of Amlodipine-Induced Gingival Overgrowth (AIGO).